MetLife, Inc. (NYSE:MET) Stock Holdings Lowered by DGS Capital Management LLC

DGS Capital Management LLC reduced its holdings in MetLife, Inc. (NYSE:METFree Report) by 8.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,051 shares of the financial services provider’s stock after selling 593 shares during the quarter. DGS Capital Management LLC’s holdings in MetLife were worth $400,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. DHJJ Financial Advisors Ltd. acquired a new stake in shares of MetLife during the third quarter valued at approximately $25,000. FWL Investment Management LLC acquired a new stake in shares of MetLife during the fourth quarter valued at approximately $26,000. Quintet Private Bank Europe S.A. acquired a new stake in shares of MetLife during the third quarter valued at approximately $28,000. Planned Solutions Inc. acquired a new stake in shares of MetLife during the fourth quarter valued at approximately $28,000. Finally, Eagle Bay Advisors LLC acquired a new stake in shares of MetLife during the second quarter valued at approximately $28,000. 89.81% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently commented on MET shares. Morgan Stanley boosted their price objective on shares of MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research report on Monday. Wells Fargo & Company boosted their price objective on shares of MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Piper Sandler boosted their target price on shares of MetLife from $74.00 to $85.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $70.00 to $80.00 in a research report on Monday, January 8th. Finally, Keefe, Bruyette & Woods boosted their target price on shares of MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $79.23.

Read Our Latest Analysis on MET

MetLife Price Performance

NYSE MET opened at $68.93 on Wednesday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.53. The company has a fifty day simple moving average of $70.95 and a 200 day simple moving average of $66.66. The company has a market cap of $49.84 billion, a P/E ratio of 37.67, a P/E/G ratio of 0.52 and a beta of 1.04. MetLife, Inc. has a 1 year low of $48.95 and a 1 year high of $74.68.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.95 by ($0.02). The firm had revenue of $18.72 billion for the quarter, compared to the consensus estimate of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. On average, sell-side analysts predict that MetLife, Inc. will post 8.71 EPS for the current year.

Insider Activity at MetLife

In related news, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the transaction, the executive vice president now directly owns 57,768 shares in the company, valued at approximately $4,174,893.36. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, insider Ramy Tadros sold 4,026 shares of the firm’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the transaction, the insider now owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Bill Pappas sold 27,000 shares of the firm’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the transaction, the executive vice president now directly owns 57,768 shares in the company, valued at approximately $4,174,893.36. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.